Search

everythinglearnresearchcommunity

for

Search:↓

Hair restoration surgery can be safely done without major bleeding in patients on antithrombotic therapy, and these drugs shouldn't be stopped before surgery.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Systemic lupus erythematosus treatment can restore vision in patients with retinal artery occlusion.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

CS12192 effectively treats alopecia areata with better safety than current options.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.